New York, NY -- (SBWIRE) -- 12/24/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: CorMedix Inc (NYSEMKT:CRMD), Cell Therapeutics Inc (NASDAQ:CTIC), Kinross Gold Corporation (USA) (NYSE:KGC), FuelCell Energy Inc (NASDAQ:FCEL)
CorMedix Inc (NYSEMKT:CRMD) showed a volume of 1.22 million shares by the end of last trade whereas the average volume of the stock remained 86,213.00 shares. The stock opened the session at $0.91 but then moved to $1.15. At that price, the stock showed a positive performance of 33.72%. CorMedix Inc. (CorMedix) is a biopharmaceutical company that focuses on in-licensing, developing and commercializing therapeutic products for the treatment of cardiac and renal dysfunction, also know as Cardiorenal disease. The Company has licensed all of the products in its Cardiorenal pipeline. The Company has several product candidates in clinical development, including its product candidates, CRMX003 (CorMedix Neutrolin),
Will CRMD Continue To Move Higher? Find Out Here
Cell Therapeutics Inc (NASDAQ:CTIC) opened the session at $1.76 and closed the session at $1.79. The stock showed a positive performance of 1.13% in previous trading session. Traded with volume of 1.07 million shares in the prior session and the average volume of the stock remained 3.23 million shares. Cell Therapeutics, Inc. (CTI) is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic ways to treats cancer. The Company is concentrating its efforts on treatments that target blood-related cancers where there is an unmet medical need. The Company is primarily focused on commercializing PIXUVRI (pixantrone) in the European Union for multiplies relapsed or refractory aggressive non-Hodgkin lymphoma (NHL),
For How Long CTIC will fight for Profitability? Read This Trend Analysis report
Kinross Gold Corporation (USA) (NYSE:KGC) opened the session at $4.28 and closed the session at $4.30. The stock showed a positive performance of 0.47% in previous trading session. Traded with volume of 12.90 million shares in the prior session and the average volume of the stock remained 9.11 million shares. The beta of the stock remained 0.64. Kinross Gold Corporation (Kinross) is engaged in gold mining and related activities, including exploration and acquisition of gold-bearing properties, the extraction and processing of gold-containing ore, and reclamation of gold mining properties. Kinross also produces and sells silver. Kinross’ gold production and exploration activities are carried out principally in Canada, the United States, the Russian Federation, Brazil,
Why Should Investors Buy KGC After The Recent Gain? Just Go Here and Find Out
FuelCell Energy Inc (NASDAQ:FCEL) the stock decreased -5.04% and finished the session at $1.32. Traded with volume of 7.08 million shares in the prior session and the average volume of the stock remained 4.85 million shares. The beta of the stock remained 2.16. FuelCell Energy, Inc. (FuelCell Energy) is a integrated fuel cell company. The Company designs, manufactures, sells, installs, operates and service ultra-clean, stationary fuel cell power plants for distributed baseload power generation. The Company’s Direct FuelCell (DFC) power plants use a range of available fuels to produce electricity electrochemically, without combustion -in a process that is quiet and produces virtually no pollutants.
Will FCEL Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)